Home/Compugen/Maytal Ziv
MZ

Maytal Ziv

Chief Medical Officer

Compugen

Therapeutic Areas

Compugen Pipeline

DrugIndicationPhase
COM701 (anti-PVRIG)Advanced solid tumorsPhase 1/2
COM902 (anti-TIGIT)Advanced solid tumorsPhase 1
Bispecific Antibody ProgramsUndisclosed cancersPreclinical